PeptideDB

Fluorescent DOTAP 1010076-97-7

Fluorescent DOTAP 1010076-97-7

CAS No.: 1010076-97-7

Fluorescent DOTAP is a cationic lipid useful in studying nucleic acid and protein delivery.
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Fluorescent DOTAP is a cationic lipid useful in studying nucleic acid and protein delivery.

Physicochemical Properties


Molecular Formula C36H60CLN5O7
Molecular Weight 710.343909263611
Exact Mass 709.418
CAS # 1010076-97-7
PubChem CID 136212472
Appearance Brown to reddish brown solid powder
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 11
Rotatable Bond Count 29
Heavy Atom Count 49
Complexity 923
Defined Atom Stereocenter Count 0
SMILES

[Cl-].O(C(CCCCCNC1=CC=C(C2C1=NON=2)[N+](=O)[O-])=O)C(COC(CCCCCCC/C=C\CCCCCCCC)=O)C[N+](C)(C)C

InChi Key XDKRQAPVOCOOGF-USGGBSEESA-M
InChi Code

InChI=1S/C36H60N5O7.ClH/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-20-23-33(42)46-29-30(28-41(2,3)4)47-34(43)24-21-19-22-27-37-31-25-26-32(40(44)45)36-35(31)38-48-39-36;/h12-13,25-26,30,37H,5-11,14-24,27-29H2,1-4H3;1H/q+1;/p-1/b13-12-;
Chemical Name

trimethyl-[2-[6-[(4-nitro-2,1,3-benzoxadiazol-7-yl)amino]hexanoyloxy]-3-[(Z)-octadec-9-enoyl]oxypropyl]azanium;chloride
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: (1). This product requires protection from light (avoid light exposure) during transportation and storage.(2). Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


References

[1]. DOTAP (and other cationic lipids): chemistry, biophysics, and transfection. Crit Rev Ther Drug Carrier Syst. 2004;21(4):257-317.


Solubility Data


Solubility (In Vitro) DMSO : ~20 mg/mL (~28.16 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2 mg/mL (2.82 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 1.4078 mL 7.0389 mL 14.0778 mL
5 mM 0.2816 mL 1.4078 mL 2.8156 mL
10 mM 0.1408 mL 0.7039 mL 1.4078 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.